(Approval lapsed) Vyvanse lisdexamfetamine dimesylate capsules 30mg (USA)

Attention Deficit Hyperactivity Disorder (ADHD) Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Treatment should be commenced by a specialist. A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before 12 years of age. Binge Eating Disorder (BED) Indicated for the treatment of moderate to severe BED in adults when non-pharmacological treatment is unsuccessful or unavailable. Treatment should be commenced and managed by a psychiatrist.